Accelerated Flap Coverage for Leg Injuries

(FLAP ATTACK Trial)

Not yet recruiting at 30 trial locations
LM
Overseen ByLily Mundy, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related complications in patients with open fractures and/or dislocations below the knee. Eligible patients will be randomized to receive either a flap within a goal of 72 hours of injury or standard of care flap timing for the institution. The primary outcome will be a composite outcome to evaluate clinical status 6 months after randomization. Components of the composite outcome will be hierarchically assessed in the following order: 1) all-cause mortality, 2) amputation related to injury, 3) re-operation for infection and/or flap complication (flap compromise, partial and/or complete flap failure), and 4) days in hospital, defined as days in an acute in-patient hospital (i.e., not rehab or nursing facility).

Who Is on the Research Team?

LH

Lily HMIR Mundy, MD

Principal Investigator

Johns Hopkins University

Are You a Good Fit for This Trial?

This trial is for people with severe leg injuries below the knee, such as open fractures or dislocations, who need flap surgery to cover wounds. Participants must be able to have surgery within a set timeframe and not have conditions that would prevent safe participation.

Inclusion Criteria

Treating surgeon is willing to comply with treatment allocation
Able to be randomized within 72 hours of injury
I am 18 years old or older.
See 1 more

Exclusion Criteria

Site is unable to implement the accelerated flap protocol due to local logistics
Other reason to exclude the patient, as approved by the Principal Investigators
Currently enrolled in a trial that does not permit co-enrollment
See 13 more

What Are the Treatments Tested in This Trial?

Interventions

  • Accelerated Flap Coverage Surgery
  • Standard of Care Flap Timing

Trial Overview

The study compares two approaches: having flap coverage surgery within 72 hours of injury (accelerated) versus waiting for the usual timing at each hospital (standard care). Patients are randomly assigned to one group or the other.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Accelerated Flap CoverageExperimental Treatment1 Intervention
Group II: Standard of Care Flap TimingActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Trials
508
Recruited
1,090,000+